Life
FDA Proposes New Policies to Enhance Domestic Drug Manufacturing
The FDA has outlined new policies in the president's budget aimed at boosting domestic drug production and enhancing manufacturing capabilities.
Editorial Staff
1 min read
The FDA's recent proposal focuses on increasing domestic drug manufacturing as part of a broader strategy to ensure supply chain resilience.
These policies are designed to enhance the capabilities of U.S. manufacturers, potentially impacting the overall drug supply infrastructure.
The initiative aligns with ongoing efforts to reduce reliance on foreign production and improve the responsiveness of domestic facilities.